Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NZSE:ATM
NZSE:ATMFood

Will a2 Milk’s New China-Focused CMO Reframe Its Brand Strategy Narrative (NZSE:ATM)?

The a2 Milk Company has appointed Helena He as Chief Marketing Officer, drawing on her extensive experience in China’s infant milk formula and vitamins, minerals and supplements sectors, effective from 23 February 2026. Her leadership roles at Haleon, FrieslandCampina and Kimberly-Clark, especially in Shanghai and broader Asian markets, align closely with a2 Milk’s core growth regions and product focus. We’ll now examine how Helena He’s China-focused brand and category expertise could...
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Community Trust Bancorp (CTBI) EPS Jump Reinforces Bullish Profitability Narrative

Community Trust Bancorp (CTBI) just wrapped up FY 2025 with fourth quarter revenue of US$71.8 million and EPS of US$1.51, capping a twelve month stretch that delivered total revenue of US$270.2 million and EPS of US$5.44. Over the past few quarters, revenue has moved from US$60.0 million in Q3 2024 to US$71.8 million in Q4 2025, while quarterly EPS has shifted from US$1.23 to US$1.51, setting up a year where net income reached US$98.1 million on a trailing basis. With net margins running in...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Garmin (GRMN) Valuation Check After New Golf Marine And Outdoor Product Launches

Garmin (GRMN) is in focus after unveiling a slate of new devices across golf, marine and outdoor categories, including the Approach G82, youth focused Approach J1, Xero L60i and quatix 8 Pro. See our latest analysis for Garmin. Despite the flurry of new product launches, Garmin's recent 90 day share price return of an 18.23% decline contrasts with a modest 1.05% share price gain year to date, while the 3 year total shareholder return of 120.37% and 5 year total shareholder return of 94.34%...
NZSE:POT
NZSE:POTInfrastructure

How Investors May Respond To Port of Tauranga (NZSE:POT) Re-lodging Fast-track Stella Passage Expansion

Port of Tauranga has re-lodged its fast-track application for the Stella Passage development in Te Awanui Tauranga Harbour, seeking approval to extend container and cargo berths, reclaim land, and carry out associated dredging within its existing footprint after legislative amendments corrected an earlier drafting error. The project’s designation as a priority under the Fast-track Approvals Act, alongside ongoing disagreement with iwi and hapū over cultural impact mitigation, underscores how...
TSE:2979
TSE:2979Industrial REITs

SOSiLA Logistics REIT (TSE:2979) DCF Upside Reinforces Bullish Valuation Narratives

Setting the scene on SOSiLA Logistics REIT’s latest numbers SOSiLA Logistics REIT (TSE:2979) has put fresh H1 2026 figures on the table, with revenue of ¥4,784.3 million and basic EPS of ¥2,745.0, backed by trailing twelve month revenue of ¥9,523.3 million and EPS of ¥5,436.0. The REIT has seen revenue move from ¥4,326.0 million in H1 2025 to ¥4,784.3 million in H1 2026, while basic EPS shifted from ¥2,452.2 to ¥2,745.0 over the same period, setting a clear earnings season backdrop for...
NYSE:FLR
NYSE:FLRConstruction

Assessing Fluor (FLR) Valuation After New Rare Earth Project Role In Texas

Fluor’s new rare earth role in Texas Fluor (FLR) has been selected by USA Rare Earth as an engineering, procurement and construction management partner for the Round Top Rare Earth Project in Texas, putting the company into focus for investors tracking critical minerals exposure. See our latest analysis for Fluor. Fluor’s selection for the Round Top project comes after it recently reached mechanical completion on BASF’s large Zhanjiang Verbund site, and the share price has shown mixed...
TSE:6146
TSE:6146Semiconductor

Disco (TSE:6146) Q3 EPS Beat Reinforces Bullish Growth Narrative Despite Rich Valuation

Disco (TSE:6146) Q3 2026 earnings in focus Disco (TSE:6146) has put up another solid top and bottom line print, with Q3 2026 revenue of ¥109,291 million and basic EPS of ¥338.71, setting the tone for how investors read the rest of the year. The company has seen revenue move from ¥93,553 million in Q3 2025 to ¥109,291 million in Q3 2026, while basic EPS over the same quarters went from ¥293.53 to ¥338.71, giving you a clear sense of the recent trajectory. Taken together with the latest...
XTRA:BAS
XTRA:BASChemicals

Is BASF (XTRA:BAS) Pricing Misaligned After Regulatory News And Mixed Long Term Returns

If you are wondering whether BASF's current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. BASF's shares last closed at €46.43, with returns of 0.3% over the past week, 6.4% over the past month, 3.7% year to date, 7.0% over one year, 7.2% over three years and a 1.7% decline over five years. Taken together, these figures give you a mixed picture of recent and longer term performance. Recent news around BASF has focused on...
NYSE:U
NYSE:USoftware

How Unity’s Coda Partnership Shapes the Next Chapter of Unity Software’s (U) Platform Strategy

In January 2026, Coda announced it had integrated Unity’s In-App Purchasing SDK with Coda’s global web store platforms, enabling developers to manage and optimize their digital catalogs across mobile, web, and PC through Unity’s existing workflow. By embedding Coda’s Merchant of Record solution into Unity’s tools, the partnership aims to simplify global payments, compliance, and fraud management so developers can run first-party web stores at scale with fewer operational hurdles. We’ll now...
SEHK:2268
SEHK:2268Life Sciences

WuXi XDC Cayman (SEHK:2268) Margin Guidance Rises on 2025 Outlook – What Is Driving Profitability?

On January 14, 2026, WuXi XDC Cayman Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference and issued unaudited guidance pointing to strong year‑on‑year increases in 2025 revenue, gross profit and net profit versus 2024. The company highlighted that gross profit is expected to grow faster than revenue, underlining improved margins and tighter cost control despite currency and interest rate headwinds. Next, we will examine how this anticipated margin expansion and profit growth...
NYSE:ARES
NYSE:ARESCapital Markets

Assessing Ares Management (ARES) Valuation After Mixed Recent Share Performance

Why Ares Management (ARES) Is On Investors’ Radar Today Ares Management (ARES) is drawing attention after recent share performance, with a decline over the past month but a gain across the past 3 months. This mixed performance is prompting closer inspection of its fundamentals. The alternative asset manager reports revenue of US$5,355.6m and net income of US$511.8m. These figures provide investors with concrete data to consider alongside recent short term share price movements. See our latest...
NYSE:MSCI
NYSE:MSCICapital Markets

Is MSCI (MSCI) Pricing Reflect Its Role In Indexes After Recent Share Weakness

If you are wondering whether MSCI's current share price lines up with what you are actually getting as an investor, this article is designed to help you assess that value question clearly. MSCI shares last closed at US$588.97, with returns of a 1% decline over the past 7 days, 2.1% over 30 days, 4.2% year to date, a 2.7% decline over 1 year, 19.9% over 3 years and 57.6% over 5 years. Recent news around MSCI has focused on its role as a provider of indexes and analytics that many institutions...
NYSE:OWL
NYSE:OWLCapital Markets

Blue Owl Capital Lawsuits Put Liquidity Disclosures And Valuation In Focus

Multiple securities class action lawsuits have been filed against Blue Owl Capital Inc. (NYSE:OWL) over alleged failures to disclose liquidity pressures and asset redemption limits at its business development companies. Plaintiffs also claim company leadership made materially misleading statements about Blue Owl Capital’s financial health and risk profile. The cases raise questions about the firm’s disclosure practices and corporate governance, with potential implications for current and...
ASX:SGLLV
ASX:SGLLVFood

ASX Dividend Stocks To Consider In January 2026

As the Australian market experiences a positive ripple effect from Wall Street's recent gains, investors are closely watching developments in international trade and commodity prices. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to navigate the current economic landscape.
ASX:POL
ASX:POLMetals and Mining

ASX Growth Companies With High Insider Ownership In January 2026

As the Australian market experiences a boost from Wall Street's positive momentum and ongoing discussions around international trade, investors are keenly observing the implications of these global developments on local indices. In this context, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the business in navigating such complex economic landscapes.
ASX:BKY
ASX:BKYOil and Gas

Berkeley Energia And 2 Other ASX Penny Stocks To Watch

As the Australian market responds positively to global developments, with a 50-point gain on the ASX following Wall Street's surge, investors are keenly watching for opportunities that balance potential growth with stability. Penny stocks, despite their somewhat dated moniker, continue to attract attention as they often represent smaller or emerging companies that can offer substantial value. By focusing on those with solid financials and a clear path forward, investors can uncover promising...
TSE:3283
TSE:3283Industrial REITs

Nippon Prologis REIT (TSE:3283) Revenue Growth Tests Bearish Forecast Narratives

Nippon Prologis REIT (TSE:3283) has posted its H1 2026 results with revenue of ¥35.1b and basic EPS of ¥1,830.23. Trailing twelve month revenue stands at ¥69.6b and EPS at ¥3,651.51, framing a set of numbers that investors can now weigh against prior periods. Over recent halves, revenue has moved from ¥31.1b in H1 2025 to ¥34.6b in H2 2025 and ¥35.1b in H1 2026. Basic EPS has shifted from ¥1,473.40 to ¥1,821.33 and then to ¥1,830.23. This latest print sits within a broader earnings...
CPSE:NSIS B
CPSE:NSIS BChemicals

Is It Too Late To Consider Novozymes (CPSE:NSIS B) After Recent Sustainability Focus?

If you are wondering whether Novozymes is attractively priced or looking stretched at today’s levels, you are in the right place for a clear, valuation focused rundown of the stock. The share price last closed at DKK 412.0, with returns of 2.6% over the past year and 25.2% over three years. Shorter term moves include a 2.4% decline over 7 days, a 1.8% gain over 30 days, and a 3.8% return year to date. Recent news coverage around Novozymes has largely centered on its role in specialty enzymes...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Broadens Cardiology And Oncology Reach As Valuation Questions Persist

Abbott Laboratories (NYSE:ABT) received CE Mark approval for its TactiFlex Duo ablation catheter for atrial fibrillation in Europe. The company is expanding further into pulsed field ablation with this dual mode catheter for heart rhythm management. Abbott also announced an acquisition of Exact Sciences to enter the cancer diagnostics market. Abbott shares last closed at $120.73, with a 1 year return of 4.4% and a 3 year return of 15.4%. The company is already a large player in medical...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave Lawsuit Puts Capacity Claims And Backlog Conversion In Spotlight

CoreWeave (NasdaqGS:CRWV) faces a material class action lawsuit alleging it misled investors about its operational capacity and supplier risk. The complaint focuses on disclosures tied to CoreWeave's reliance on a single third party data center supplier and its ability to meet AI infrastructure demand. The lawsuit follows a revenue guidance reduction, termination of a major merger, and delays in data center development. CoreWeave runs GPU focused cloud infrastructure for AI workloads, a...
ASX:WES
ASX:WESMultiline Retail

Infinity Pharmacy Collapse Might Change The Case For Investing In Wesfarmers' Health Push (ASX:WES)

Wesfarmers recently walked away from a last-minute rescue deal for Infinity Pharmacy Group, leaving more than 50 Priceline-branded pharmacies in receivership with creditors reportedly owed over A$400 million and raising questions about the impact on its health division. The Infinity collapse highlights the risks within Wesfarmers’ wholesale pharmacy exposure and puts extra focus on how management positions the health portfolio alongside core retail brands like Bunnings and Kmart. With this...
ASX:LOT
ASX:LOTOil and Gas

Assessing Lotus Resources (ASX:LOT) Valuation After Share Consolidation And Capital Structure Update

What triggered the latest interest in Lotus Resources? Lotus Resources (ASX:LOT) has drawn fresh attention after completing an 11.5 for 1 share consolidation, updating its capital structure details, and recording a sharp, high volume intraday move on 21 January 2026. See our latest analysis for Lotus Resources. The recent 11.5 for 1 share consolidation and updated capital structure details arrive after a period where the share price has shown strong short term momentum, with a 30 day share...
NYSE:LH
NYSE:LHHealthcare

Expanded MRD Test Suite and Dividend Hike Might Change The Case For Investing In Labcorp (LH)

In January 2026, Labcorp Holdings Inc. expanded its molecular residual disease (MRD) testing portfolio with new Plasma Detect ID and Plasma Detect Genome assays for earlier detection of cancer recurrence, while its Board approved a US$0.72 per-share cash dividend payable on March 12, 2026, to shareholders of record on February 27, 2026. The broadened MRD offering, supported by clinical studies across several tumor types, strengthens Labcorp’s role in precision oncology and personalized...